Understanding how immune system dysfunction shapes brain development could transform approaches to autism spectrum disorders, offering new therapeutic targets beyond behavioral interventions. The intricate relationship between inflammation and neural network formation suggests that autism may be fundamentally rooted in immune-brain communication breakdowns during critical developmental windows.
Comprehensive analysis across multiple research approaches reveals that individuals with autism consistently exhibit activated microglia and astroglia—the brain's primary immune cells—alongside elevated inflammatory markers including interleukin-1β, interleukin-6, and tumor necrosis factor-α. These inflammatory signatures coincide with oxidative stress markers, particularly glutathione imbalances and lipid peroxidation damage. Neuroimaging data demonstrates that these biochemical alterations correlate with disrupted connectivity within three major brain networks: the default mode network governing self-referential thinking, the salience network managing attention allocation, and executive control systems responsible for cognitive flexibility.
This convergence of immune dysfunction and connectivity alterations represents a significant conceptual advance in autism research, moving beyond purely genetic or behavioral frameworks toward integrated immune-neurological models. The findings suggest that targeting neuroinflammation could potentially influence core autism symptoms by restoring healthy network communication patterns. However, the field remains limited by predominantly correlational evidence and unclear causality—whether inflammation drives connectivity changes or vice versa. Additionally, most studies examine established autism cases rather than tracking inflammatory processes during the critical early developmental period when intervention might prove most effective.